Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement

被引:9
|
作者
Lebel, Ehud [1 ]
Elstein, Deborah [2 ]
Peleg, Ariel [2 ]
Remus, Constantine [3 ]
Zimran, Ari [2 ]
Amir, Gail [4 ]
机构
[1] Shaare Zedek Med Ctr, Dept Orthoped Surg, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[3] Shaare Zedek Med Ctr, Dept Pathol, IL-91031 Jerusalem, Israel
[4] Hadassah Med Ctr, Dept Pathol, Ein Kerem, Israel
关键词
Gaucher disease; Gaucher cells; Bone histology; Enzyme replacement therapy; Osteonecrosis; OSTEONECROSIS;
D O I
10.1309/AJCPFVSAEGO67NGT
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: To assess correlations of patient demographics, including enzyme replacement therapy (ERT) with bone histology, to facilitate decisions of whether and when to perform hip replacement surgery in patients with Gaucher disease. Methods: We examined the histology of surgically removed femoral heads and categorized findings by the presence or extent of osteonecrosis, Gaucher cell (GC) infiltration, and bone regeneration qualifiers using a tripartite histology-based scoring system. Results: Twenty-two patients with 26 bone specimens were evaluated. Seventeen patients (77%) were splenectomized, 16 (73%) received ERT, and 12 (55%) had the putatively milder genotype (N370S/N370S), with the rest putatively at increased risk for skeletal disease (N370S/other). The 3 histology subscores were applicable to all specimens. Osteonecrotic bone was seen in 19 of 26 (73%); osteoarthritis was seen in all cartilage specimens. Gaucher cell infiltration was not correlated with demographics or disease severity. A trend was noted between reduced GC infiltration and ERT (rho = 0.407), but regeneration qualifiers were not correlated with ERT or other features. Conclusions: Histologic findings of GC infiltration and bone regeneration qualifiers did not correlate with demographics or with exposure to ERT. Most specimens unexpectedly showed good regenerative responses to osteonecrosis despite heavy GC infiltration.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [41] Gaucher disease and enzyme replacement therapy, Iranian experience
    Zaman, T.
    Roya, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 46 - 46
  • [43] Response of Gaucher bone disease to enzyme replacement therapy
    Poll, LW
    Maas, M
    Terk, MR
    Roca-Espiau, M
    Bembi, B
    Ciana, G
    Weinreb, NJ
    BRITISH JOURNAL OF RADIOLOGY, 2002, 75 : A25 - A36
  • [44] Breastfeeding in Gaucher Disease: Is Enzyme Replacement Therapy Safe?
    Dornelles, Alicia Dorneles
    de Oliveira Netto, Cristina Brinckmann
    Vairo, Filippo
    de Mari, Jurema Fatima
    Tirelli, Kristiane Michelin
    Schwartz, Ida Vanessa D.
    CLINICAL THERAPEUTICS, 2014, 36 (06) : 990 - 991
  • [45] Enzyme replacement therapy in type 2 Gaucher disease
    Tournay, A
    Parker, C
    Schiffman, R
    Brady, R
    Barton, N
    NEUROLOGY, 1996, 46 (02) : 1106 - 1106
  • [46] Enzyme replacement therapy in type III Gaucher disease
    Tylki-Szymanska, A
    Czartoryska, B
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) : 203 - 204
  • [47] Thrombocytosis associated with in enzyme replacement therapy in Gaucher disease
    Dweck, A
    Blickstein, D
    Elstein, D
    Zimran, A
    ACTA HAEMATOLOGICA, 2002, 108 (02) : 94 - 96
  • [48] Effect of enzyme replacement therapy on gammopathies in Gaucher disease
    Brautbar, A
    Elstein, D
    Pines, G
    Abrahamov, A
    Zimran, A
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) : 214 - 217
  • [49] Enzyme replacement therapy for Gaucher disease in twin pregnancy
    Malinova, Vera
    Poupetova, Helena
    Dvorakova, Lenka
    Zeman, Jiri
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 106 (01) : 64 - 66
  • [50] Enzyme replacement and substrate reduction therapy for Gaucher disease
    Shemesh, Elad
    Deroma, Laura
    Bembi, Bruno
    Deegan, Patrick
    Hollak, Carla
    Weinreb, Neal J.
    Cox, Timothy M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):